These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 20977903)
21. L1cam acts as a modifier gene during enteric nervous system development. Wallace AS; Schmidt C; Schachner M; Wegner M; Anderson RB Neurobiol Dis; 2010 Dec; 40(3):622-33. PubMed ID: 20696247 [TBL] [Abstract][Full Text] [Related]
22. Haplotypes of the human RET proto-oncogene associated with Hirschsprung disease in the Italian population derive from a single ancestral combination of alleles. Lantieri F; Griseri P; Puppo F; Campus R; Martucciello G; Ravazzolo R; Devoto M; Ceccherini I Ann Hum Genet; 2006 Jan; 70(Pt 1):12-26. PubMed ID: 16441254 [TBL] [Abstract][Full Text] [Related]
23. Identification of Variants in RET and IHH Pathway Members in a Large Family With History of Hirschsprung Disease. Sribudiani Y; Chauhan RK; Alves MM; Petrova L; Brosens E; Harrison C; Wabbersen T; de Graaf BM; Rügenbrink T; Burzynski G; Brouwer RWW; van IJcken WFJ; Maas SM; de Klein A; Osinga J; Eggen BJL; Burns AJ; Brooks AS; Shepherd IT; Hofstra RMW Gastroenterology; 2018 Jul; 155(1):118-129.e6. PubMed ID: 29601828 [TBL] [Abstract][Full Text] [Related]
24. RET and PHOX2B genetic polymorphisms and Hirschsprung's disease susceptibility: a meta-analysis. Liang CM; Ji DM; Yuan X; Ren LL; Shen J; Zhang HY PLoS One; 2014; 9(3):e90091. PubMed ID: 24651702 [TBL] [Abstract][Full Text] [Related]
25. Kidney malformations and Hirschsprung's disease in carriers of cysteine mutations in exon 10 of the RET proto-oncogene. Machens A; Lorenz K; Dralle H Endocrine; 2021 Jul; 73(1):217-222. PubMed ID: 33754314 [TBL] [Abstract][Full Text] [Related]
26. Occurrence of MEN 2a in familial Hirschsprung's disease: a new indication for genetic testing of the RET proto-oncogene. Decker RA; Peacock ML J Pediatr Surg; 1998 Feb; 33(2):207-14. PubMed ID: 9498388 [TBL] [Abstract][Full Text] [Related]
27. Functional haplotypes of the RET proto-oncogene promoter are associated with Hirschsprung disease (HSCR). Fitze G; Appelt H; König IR; Görgens H; Stein U; Walther W; Gossen M; Schreiber M; Ziegler A; Roesner D; Schackert HK Hum Mol Genet; 2003 Dec; 12(24):3207-14. PubMed ID: 14600022 [TBL] [Abstract][Full Text] [Related]
28. Discrepancy between macroscopic and microscopic transitional zones in Hirschsprung's disease with reference to the type of RET/GDNF/SOX10 gene mutation. Shimotake T; Tomiyama H; Aoi S; Iwai N J Pediatr Surg; 2003 May; 38(5):698-701. PubMed ID: 12720173 [TBL] [Abstract][Full Text] [Related]
29. Association study of PHOX2B as a candidate gene for Hirschsprung's disease. Garcia-Barceló M; Sham MH; Lui VC; Chen BL; Ott J; Tam PK Gut; 2003 Apr; 52(4):563-7. PubMed ID: 12631670 [TBL] [Abstract][Full Text] [Related]
30. Haplotype analysis reveals a possible founder effect of RET mutation R114H for Hirschsprung's disease in the Chinese population. Cornes BK; Tang CS; Leon TY; Hui KJ; So MT; Miao X; Cherny SS; Sham PC; Tam PK; Garcia-Barcelo MM PLoS One; 2010 Jun; 5(6):e10918. PubMed ID: 20532249 [TBL] [Abstract][Full Text] [Related]
31. A study on genetic polymorphism of RET proto-oncogene in Hirschsprung's disease in children. Kumari M; Das C; Mukhopadhyay M; Patra RD; Mitra PK; Mukhopadhyay B Afr J Paediatr Surg; 2020; 17(3 & 4):104-107. PubMed ID: 33342844 [TBL] [Abstract][Full Text] [Related]
32. A common variant located in the 3'UTR of the RET gene is associated with protection from Hirschsprung disease. Griseri P; Lantieri F; Puppo F; Bachetti T; Di Duca M; Ravazzolo R; Ceccherini I Hum Mutat; 2007 Feb; 28(2):168-76. PubMed ID: 16986122 [TBL] [Abstract][Full Text] [Related]
33. [Genetic bases of Hirschsprung's disease]. Passarge E; Bruder E Pathologe; 2007 Mar; 28(2):113-8. PubMed ID: 17285323 [TBL] [Abstract][Full Text] [Related]
34. Reduced RET expression in gut tissue of individuals carrying risk alleles of Hirschsprung's disease. Miao X; Leon TY; Ngan ES; So MT; Yuan ZW; Lui VC; Chen Y; Wong KK; Tam PK; Garcia-Barceló M Hum Mol Genet; 2010 Apr; 19(8):1461-7. PubMed ID: 20089534 [TBL] [Abstract][Full Text] [Related]
35. SLIT2/ROBO1-miR-218-1-RET/PLAG1: a new disease pathway involved in Hirschsprung's disease. Tang W; Tang J; He J; Zhou Z; Qin Y; Qin J; Li B; Xu X; Geng Q; Jiang W; Wu W; Wang X; Xia Y J Cell Mol Med; 2015 Jun; 19(6):1197-207. PubMed ID: 25786906 [TBL] [Abstract][Full Text] [Related]
36. Chinese patients with sporadic Hirschsprung's disease are predominantly represented by a single RET haplotype. Garcia-Barceló MM; Sham MH; Lui VC; Chen BL; Song YQ; Lee WS; Yung SK; Romeo G; Tam PK J Med Genet; 2003 Nov; 40(11):e122. PubMed ID: 14627689 [No Abstract] [Full Text] [Related]
37. A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma. Borrego S; Wright FA; Fernández RM; Williams N; López-Alonso M; Davuluri R; Antiñolo G; Eng C Am J Hum Genet; 2003 Jan; 72(1):88-100. PubMed ID: 12474140 [TBL] [Abstract][Full Text] [Related]
38. Effect of 3'UTR RET Variants on RET mRNA Secondary Structure and Disease Presentation in Medullary Thyroid Carcinoma. Ceolin L; Romitti M; Siqueira DR; Vaz Ferreira C; Oliboni Scapineli J; Assis-Brazil B; Vieira Maximiano R; Dias Amarante T; de Souza Nunes MC; Weber G; Maia AL PLoS One; 2016; 11(2):e0147840. PubMed ID: 26829565 [TBL] [Abstract][Full Text] [Related]
39. Association analysis of the RET proto-oncogene with Hirschsprung disease in the Han Chinese population of southeastern China. Liu CP; Tang QQ; Lou JT; Luo CF; Zhou XW; Li DM; Chen F; Li X; Li JC Biochem Genet; 2010 Jun; 48(5-6):496-503. PubMed ID: 20454948 [TBL] [Abstract][Full Text] [Related]